Spectrum Management Group’s ResMed RMD Stock Holding History

Spectrum Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500	Closed	-$57K	–	270
2018 Q4	$57K	Hold	500	–	–	0.02%	118
2018 Q3	$58K	Hold	500	–	–	0.02%	123
2018 Q2	$52K	Hold	500	–	–	0.02%	127
2018 Q1	$49K	Hold	500	–	–	0.02%	123
2017 Q4	$42K	Hold	500	–	–	0.01%	135
2017 Q3	$38K	Buy	+500	New	+$38.2K	0.01%	187
2016 Q2	–	Sell	-500	Closed	-$29K	–	193
2016 Q1	$29K	Hold	500	–	–	0.01%	160
2015 Q4	$27K	Buy	+500	New	+$28.2K	0.01%	144

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Spectrum Management Group's RMD Position: Q1 2019 in Review

Spectrum Management Group sold out of ResMed (RMD) in Q1 2019, closing a stake of 500 shares — an estimated $57K sold.

Spectrum Management Group first reported a position in RMD in Q4 2015 and held it in 8 quarters. The position peaked at $58K in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

Spectrum Management Group reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
Spectrum Management Group sold 500 ResMed shares in Q1 2019, an estimated $57K.
Spectrum Management Group first reported a position in ResMed in Q4 2015 and held it in 8 quarters.
Spectrum Management Group's ResMed position peaked at $58K in Q3 2018.
477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Spectrum Management Group's 13F filing for Q1 2019, filed 16 Apr 2019.